The Community Recruitment and Retention (CRR) Shared Facility is an infrastructure designed to facilitate and assist CCC investigators in recruiting subjects to participate in clinical research and to provide linkage between the community and UAB Researchers. The Facility: 1) provides CCC researchers with diverse recruitment services (for example, designing recruitment strategies, recruiting subjects, developing recruitment materials and advertisements, etc.); 2) provides and maintains the necessary linkage between CCC researchers and the surrounding communities, including potential research subjects, community-based organizations, community leaders, and community health care providers; 3) disseminates culturally appropriate information regarding techniques for recruitment and retention of minority subjects suitable for UAB investigators; and 4) establishes and maintains an information system with a Recruitment Data Base (RDB) comprised of a Mass Mailing System (MMS), a Recruitment Tracking System (RTS), and a Health Profile System (HPS) to identify subjects with certain health profiles of interest to UAB investigators. Since its inception the CRR facility has had accrual of over 24,000 individuals participating in 23 cancer studies of which 42% of the participants were minorities and 78% women. In the last four years, the CRR focused its efforts on refining minority population recruitment strategies, especially for population-based studies. We also developed state-of-the-art information and tracking systems, finalized the operational procedures, and reinforced and developed new partnerships with community organizations and health care providers. The CRR remains timely and has significant research implications. Having in place a centralized database, an infrastructure, and expertise with general and minority-specific recruitment strategies, rather than rebuilding with each study, is of critical importance to CCPS and chemoprevention investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-36
Application #
7414796
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-05-01
Project End
2010-03-31
Budget Start
2007-05-01
Budget End
2008-03-31
Support Year
36
Fiscal Year
2007
Total Cost
$208,813
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Carson, Tiffany L; Wang, Fuchenchu; Cui, Xiangqin et al. (2018) Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress. Psychosom Med 80:640-648
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62
Frugé, Andrew D; Cases, Mallory G; Howell, Carrie R et al. (2018) Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors. Cancer Causes Control 29:185-191
McCaw, Tyler R; Randall, Troy D; Arend, Rebecca C (2018) Overcoming immune suppression with epigenetic modification in ovarian cancer. Transl Res :
Geng, Mengxin; Austin, Frank; Shin, Ronald et al. (2018) Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2. Appl Environ Microbiol 84:
Samykutty, Abhilash; Grizzle, William E; Fouts, Benjamin L et al. (2018) Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials 182:114-126
Friedman, Gregory K; Bernstock, Joshua D; Chen, Dongquan et al. (2018) Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression. Sci Rep 8:13930
Powell, T Clark; Dilley, Sarah E; Bae, Sejong et al. (2018) The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical Cancer. J Low Genit Tract Dis 22:269-273
Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:
Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27

Showing the most recent 10 out of 747 publications